Hi Michael - yes, research is frustratingly slow sometimes, including all the long-winded processes that any drug candidate needs to go through to get to the people who need it.
We try to fight it as much as we can! And we're actually feeling quite hopeful about this new dataset, as it's not only analyzing the possible causes of stalls (so not just shooting in the dark), but could suggest very specific treatment targets.
Plus, our biomedical collaborators at Cornell are actually doing more research regarding drug screening, but not all of it goes through Stall Catchers! They will in fact be screening FDA approved drugs soon, but using a different method - blood flow measurement (that is faster) for the first screen, which should start this Fall/Winter. Any drugs that look promising would be followed by capillary stall analysis, i.e. via Stall Catchers.
Hope this helps, and patience to us all!